These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18370239)

  • 1. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of pharmacogenetics in gastrointestinal diseases.
    Saito YA; Camilleri M
    Expert Opin Pharmacother; 2006 Oct; 7(14):1857-69. PubMed ID: 17020413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.
    Herrlinger KR; Jewell DP
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1403-12. PubMed ID: 17081161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(3):150-7. PubMed ID: 14502119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: thiopurines in inflammatory bowel disease.
    Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
    Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in inflammatory bowel disease.
    Egan LJ; Derijks LJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):21-8. PubMed ID: 16431300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease.
    Holbrook K
    J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in gastrointestinal disorders.
    Schreiber S; Costello CM
    Eur J Surg Suppl; 2002; (587):70-6. PubMed ID: 16144204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of inflammatory bowel disease.
    Kelleher D; Farrell R; McManus R
    Novartis Found Symp; 2004; 263():41-53; discussion 53-6, 211-8. PubMed ID: 15669633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications.
    Camilleri M
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():40-5. PubMed ID: 17620087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of colorectal cancer prevention and treatment.
    Nguyen H; Tran A; Lipkin S; Fruehauf JP
    Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomics in gastroenterologic diseases].
    Redal MA; Scibona P; Garfi LG; Isolabella S; Argibay P; Belloso WH
    Acta Gastroenterol Latinoam; 2012 Mar; 42(1):64-72. PubMed ID: 22616502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances of molecular clinical pharmacology in gastroenterology and hepatology.
    Prandota J
    Am J Ther; 2010; 17(5):e137-62. PubMed ID: 19433977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.
    Katzka DA; Loftus EV; Camilleri M
    Clin Pharmacol Ther; 2012 Sep; 92(3):306-20. PubMed ID: 22828717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
    Roberts RL; Barclay ML
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1546-54. PubMed ID: 22741564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.